Drugs / EcoActive
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03808103 | May 2019 → Jun 2026 overdue | Crohn disease | Intralytix, Inc. | Active not recruiting | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2023-08-01 | Intralytix, Inc. | Intralytix's EcoActive Phase 1/2a Phage Trial Begins Enrollment at Johns Hopkins University in the Baltimore, Maryland Metro Area intralytix.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EcoActive | “EcoActive is a collection of bacteriophages.” NCT03808103 ↗ |
| Modality | Other / unclassified | “EcoActive is a collection of bacteriophages.” NCT03808103 ↗ |
| Route | Oral | “Dose is 1mL of bacteriophage preparation given orally twice a day for 15 days” NCT03808103 ↗ |